Clinical Trials Consumption Data Epilepsy 
Project CBD
MARCH 21, 2023
Auditory & Other Symptoms The survey, whose findings were published in February 2023 in the Journal of Otolaryngology – Head & Neck Surgery 1 evaluated cannabis perceptions and consumption among 45 adult tinnitus patients randomly selected and recruited from an outpatient ear, nose, and throat clinic in Ontario, Canada.
Veriheal
MARCH 23, 2023
The disparities in consumption could be attributed to the fact that Japan implements harsh laws forbidding the use, production, and importation of illicit substances. Data suggests that the market has inflated from JPY4 billion (USD$3 billion) in 2019 to JPY17 billion (USD$13 billion) in 2022. Around 0.2%
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Care Docs
DECEMBER 16, 2020
As with any prescription, marijuana does not offer a one-size-fits-all solution: there are a range of products available with different strains, chemical structures, dosages, and forms of consumption that all can impact the effectiveness for each user. Research is ongoing, but the existing data and anecdotal reports show potential.
The Cannigma
JUNE 15, 2021
The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. However, the scientific data on CBG is nowhere near as developed as what we have on CBD. Shutterstock). It’s everywhere. An anti-seizure wonder drug.
Veriheal
AUGUST 31, 2020
Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” . School: Tufts University.
CannaTech
SEPTEMBER 16, 2018
But this gap restricts patient access to a medicine that can offer relief to a long list of conditions including chronic pain, seizures attributed to epilepsy, as well as mood disorders such as anxiety and depression. This knowledge gap isn’t surprising, as cannabis as a medicine is non-traditional in its very nature.
Greencamp
AUGUST 16, 2018
The CBD cannabinoid is proven to be an exceptional seizure-controlling agent for epilepsy patients, and also shows great promise for treating Parkinson’s , Alzheimer’s and Multiple Sclerosis. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies). Exploring the available research on ALS and cannabinoids.
Expert insights. Personalized for you.
144 
Let's personalize your content